Obesity
Not recruitingA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
- Disease:Obesity
- Substances:–
Czechia- Participants:18–64 years · 65+ years
- Sponsor:Metsera Inc.
Rare diseases
Investigational molecules
Locations
Back to Czechia45 clinical trials in Jihlava, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on multiple sclerosis treatments, including studies of novel therapies like frexalimab and comparative analyses of established medications. Clinical trials are evaluating both relapsing and progressive forms of MS, with emphasis on long-term efficacy and safety.
Several trials are investigating new delivery methods and formulations to improve patient outcomes.
Innovative studies targeting cardiovascular diseases, including trials for heart failure, myocardial infarction, and stroke prevention. Research includes evaluation of new compounds for reducing cardiovascular events and improving patient outcomes.
Focus on both preventive measures and acute treatment strategies for cardiovascular conditions.
Clinical trials examining new treatments for severe asthma and related respiratory conditions. Studies are evaluating novel medications and delivery systems to improve symptom control and reduce exacerbations.
Research emphasizes both immediate symptom relief and long-term disease control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.